On May 19, President Donald Trump’s Domestic Policy Council is expected to submit policy recommendations to improve access to ...

Harvard Medical School developmental biologist Olivier Pourquié is no stranger to scientific honors. He has received research ...

Even the troublesome symptoms of menopause, such as hot flashes and night sweats, can be a useful “disruptor” in people’s ...

InVitria launches Optibumin® 25, the first recombinant 25% rHSA for closed-system use, enabling safer, scalable biomanufacturing.

While embryonic children must be treated as persons, the church distinguishes regular adoption, or adoption after birth, from embryo adoption.

BioIVT, a global research partner and biospecimen solutions provider for drug and diagnostic development, today announced the launch of VivoSTARTtm Cryopreserved GMP Leukopaks. The GMP-compliant ...

Optibumin® 25 is the first recombinant 25% human serum albumin for closed ... formulation, and cryopreservation workflows. The product is currently available in 100 mL single-use bags and is ...

Tardigrades are already the stuff of legend — tiny, eight-legged creatures that can survive freezing, boiling, starvation, ...

LeMaitre Vascular ranks highest in Revenue Growth among its peers. It also leads in Gross Profit margin. However, it has the ...

As the demand for viral vectors rises in new gene therapy approaches, scientists seek ways to optimize their production.